Contact Us

ReNu Contact Solution
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

FDA: B&L lens-solution recall permanent

May 15, 2006 | UPI

The Food and Drug Administration Monday gave an update on Bausch & Lomb's probe into its ReNu lens solution's link to infection.

In a statement, the FDA said it met with Bausch & Lomb May 11 to get information on the company's internal investigation into several cases of the eye infection Fusarium keratitis associated with the contact-lens solution ReNu with MoistureLoc.

The FDA said, "Bausch & Lomb has proposed that unique characteristics of the formulation of the ReNu with MoistureLoc product in certain unusual circumstances can increase the risk of Fusarium infection," an infection that can cause blindness if not treated.

"Based on this scientific and epidemiological data suggesting that ReNu with MoistureLoc may increase susceptibility to Fusarium, Bausch & Lomb has decided to permanently remove the ReNu with MoistureLoc product worldwide," the FDA said. The agency said it supported the company's decision.

"To date, data available do not indicate a problem with ReNu MultiPlus or ReNu Multi-Purpose or generic brands of this contact lens cleaning solution," the agency added.

Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo